Shoemaker, Robert H.
National Cancer Institute
7 papers on CoChatORCID 0000-0003-3608-1714
Most cited papers
- Verified
Echinomycin, a small-molecule inhibitor of hypoxia-inducible factor-1 DNA-binding activity.
Kong, D., Park, E. J., Stephen, A. G., Calvani, M., Cardellina, J. H., Monks, A., Fisher, R. J., Shoemaker, R. H., & Melillo, G. (2005) · Cancer Research
Cancer, Hypoxia, and MetabolismHeterocyclic Compound Synthesis and Bioactivity
Cited by 508
- Verified
Topoisomerase I-Mediated Inhibition of Hypoxia-Inducible Factor 1
Rapisarda, A., Uranchimeg, B., Sordet, O., Pommier, Y., Shoemaker, R. H., & Melillo, G. (2004) · Cancer Research
Cancer therapeutics and mechanismsCancer, Hypoxia, and Metabolism
Cited by 301
- Verified
Schedule-dependent Inhibition of Hypoxia-inducible Factor-1α Protein Accumulation, Angiogenesis, and Tumor Growth by Topotecan in U251-HRE Glioblastoma Xenografts
Rapisarda, A., Zalek, J., Hollingshead, M., Braunschweig, T., Uranchimeg, B., Bonomi, C. A., Borgel, S. D., Carter, J. P., Hewitt, S. M., Shoemaker, R. H., et al. (2004) · Cancer Research
Cancer, Hypoxia, and MetabolismCancer therapeutics and mechanisms
Cited by 187
- Verified
Increased antitumor activity of bevacizumab in combination with hypoxia inducible factor-1 inhibition
Rapisarda, A., Hollingshead, M., Uranchimeg, B., Bonomi, C. A., Borgel, S. D., Carter, J. P., Gehrs, B., Raffeld, M., Kinders, R. J., Parchment, R., et al. (2009) · Molecular Cancer Therapeutics
Cancer, Hypoxia, and MetabolismAngiogenesis and VEGF in Cancer
Cited by 171
- Verified
Differential involvement of vascular endothelial growth factor in the survival of hypoxic colon cancer cells
Calvani, M., Trisciuoglio, D., Bergamaschi, C., Shoemaker, R. H., & Melillo, G. (2008) · Cancer Research
Angiogenesis and VEGF in CancerCancer, Hypoxia, and Metabolism
Cited by 80
- Verified
Targeting Topoisomerase 1 to inhibit Hypoxia Inducible Factor 1
Rapisarda, A., Shoemaker, R. H., & Melillo, G. (2004) · Cell Cycle
Cancer, Hypoxia, and MetabolismCancer therapeutics and mechanisms
Cited by 41
- Verified
Immunoprevention of KRAS-driven lung adenocarcinoma by a multipeptide vaccine
Pan, J., Zhang, Q., Sei, S., Shoemaker, R. H., Lubet, R. A., Wang, Y., & You, M. (2017) · Oncotarget
Immunotherapy and Immune Responsesvaccines and immunoinformatics approaches
Cited by 38
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free